Study results show semaglutide for weight loss (Wegovy) cut problems in the heart and blood vessels in a 17,000-person trial, which should reframe the health benefit of this weight loss drug.
from WebMD Health https://ift.tt/CmFYrP6
Study results show semaglutide for weight loss (Wegovy) cut problems in the heart and blood vessels in a 17,000-person trial, which should reframe the health benefit of this weight loss drug.
Identifying specific genes adds to growing evidence that biology, in part, drives obesity. Researchers hope the findings will lead to effective treatments.
A study found that videos using motivational behavior often provide misleading information – or medical advice provided by a doctor for the influencer’s specific situation, not the public at large.
Giving to others isn't just generous – it's healthy and linked to longer life. Here's what's going on in your body when you help someone.